Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (278)
- COVID-19 (163)
- Safety monitoring and information (102)
- Legislation (95)
- Compliance and enforcement (70)
- Manufacturing (55)
- Vaping hub (55)
- Labelling and packaging (37)
- Import and export (28)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Sunscreens (16)
- Weight loss products (15)
- Shortages and supply disruptions (14)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Type of content
Search
69 result(s) found, displaying 51 to 69
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Indications) Determination has been updated
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Media releasesToday the TGA announced a final decision to down-schedule certain low dose cannabidiol (CBD) preparations
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
BlogHow to find information about the inactive ingredients in your medicines.
-
Regulatory decision noticesListed medicine ingredients and requirements have been updated.
-
Regulatory decision noticesThe Permissible Ingredients Determination has been updated.
-
Regulatory decision noticesThe Permissible Ingredients Determination has been updated.
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Indications) Determination has been updated
-
Regulatory decision noticesAn amendment to the Therapeutic Goods (Permissible Ingredients) Determination commenced on 2 September 2019.
-
News articlesChanges will be made to the regulation of nappy rash products on 1 January 2020
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
News articlesIndications proposed by industry during the 2017 public comment period have been published
-
Regulatory decision noticesThis instrument applies to an application to list a complementary medicine under section 26AE of the Act.
-
Regulatory decision noticesThis instrument applies to an application to register a complementary medicine
-
Regulatory decision noticesGarcinia gummi-gutta, also commonly known as Garcinia cambogia, can be used as an ingredient in lower-risk (listed) medicines.